A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

NCT00678795 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Detrusor Overactivity
Multiple Sclerosis

Interventions

DRUG: Sativex®
DRUG: Placebo

Sponsor

Jazz Pharmaceuticals